SCHEMBL23120210

SCHEMBL23120210

c1ccc(-c2nc3cc(-n4c5ccccc5c5cc(-c6ccc7c(c6)c6ccccc6n7-c6ccccc6)ccc54)ccc3[nH]2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 5/20 0.45
▸ NPC1 O15118 2/20 0.44
▸ GAA P10253 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ KDM4E B2RXH2 3/20 0.43
▸ PTGER4 P35408 1/20 0.43
▸ ATM Q13315 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ CHEK2 O96017 3/20 0.41
▸ PDE10A Q9Y233 1/20 0.40
▸ HPGD P15428 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ GLA P06280 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ GFER P55789 1/20 0.39
▸ RCE1 Q9Y256 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29949312 1.00 NPY5R (0.45) NPY5RNPC1GAARAB9AKDM4E
SCHEMBL29949115 0.96 NPY5R (0.46) NPY5RNPC1GAARAB9AKDM4E
SCHEMBL23120186 0.96 NPY5R (0.46) NPY5RNPC1GAARAB9AKDM4E
SCHEMBL23132196 0.93 NPY5R (0.49) NPY5RNPC1GAARAB9AKDM4E
SCHEMBL15773490 0.88 CHEK2 (0.43) NPY5RNPC1GAARAB9AKDM4E
SCHEMBL24501022 0.87 NPC1 (0.50) NPY5RNPC1GAARAB9AKDM4E
SCHEMBL21298554 0.86 NPY5R (0.53) NPY5RNPC1GAARAB9AKDM4E
SCHEMBL23131911 0.86 NPY5R (0.54) NPY5RNPC1GAARAB9AKDM4E
SCHEMBL23131914 0.84 PDE10A (0.44) NPY5RNPC1GAARAB9AKDM4E
SCHEMBL23948708 0.83 NPY5R (0.50) NPY5RNPC1GAARAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220384735-A1 PERI-CONDENSED HETEROCYCLIC COMPOUNDS AS MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2022-12-01 — — US disclosed
EP-4031549-A1 PERI-CONDENSED HETEROCYCLIC COMPOUNDS AS MATERIALS FOR ELECTRONIC DEVICES Merck Patent GmbH (DE) 2022-07-27 — — EP disclosed
WO-2021053046-A1 PERI-CONDENSED HETEROCYCLIC COMPOUNDS AS MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2021-03-25 — — WO disclosed
WO-2021053046-A1 PERI-CONDENSED HETEROCYCLIC COMPOUNDS AS MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2021-03-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220384735-A1 PERI-CONDENSED HETEROCYCLIC COMPOUNDS AS MATERIALS FOR ELECTRONIC DEVICES KCNH1, NES, KCNC1 NPY5R 3702/4885NPC1 3475/4885GAA 3899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback